Buying NOVO B shares on the Copenhagen exchange (NOVO-B.CO) does not directly influence the price of Novo Nordisk’s ADRs (American Depository Receipts) listed on U.S. exchanges. However, the two are closely related.
NOVO B shares in Copenhagen and Novo Nordisk ADRs (listed as NVO in the U.S.) both represent shares in the same company, and their prices generally move in tandem due to arbitrage. If the price of NOVO B shares increases significantly, it typically drives up demand for the ADRs, as investors expect similar performance from both listings.